David D'Alton, CEO
Concepts and start-ups to profitable business, 30-years international business development including UK, Ireland, mainland Europe, the United States and Japan. Formerly IBM and DEC executive in trading systems to Financial Services sector. Experienced in complex technology bids and projects and capital raising. MNC account management, international business and trade development, operational management, executive search and interim management. Former UK Director British Irish Chamber of Commerce.
James Mackrill, COO
Former Regional Director Enterprise Ireland widely experienced in high-growth SME and start-up business commercialisation. Market evaluation, differentiated strategy development with implementation and results delivery. Experienced in governmental and regional trade development agency initiatives, strategic international business development; international sales and marketing.
Chris Howie, UK Dept International Trade, European Life Sciences Specialist
EuroGate Strategic Partner. Extensive 25-year commercial healthcare experience with significant track record in European business development from start-ups to blue chips in biotechnology, medical technology and diagnostics. Significant experience integrating companies with the UK National Health Service and an in-depth understanding of business commercialisation tracks through to exits in both the UK and EU healthcare markets. Assists scaling European healthcare companies in bringing their sciences, technologies and investment to the UK.
Dr Dirk Stynen, EuroGate Strategic Partner & President, Qarad Regulatory
PhD in Biology, Postgraduate Studies in Enterprise Economics, fluent in four languages. Widely experienced in scientific research, diagnostic assay development, quality system implementation, clinical studies and regulatory affairs. Participates in the European Union’s IVD Technical Group. Accomplished in Regulatory Affairs, Quality Assurance and Clinical Studies, has supported IVD and Medical Device manufacturers with CE marking and ISO13485 certification. Formerly of Innogenetics N.V., also of Sanofi Diagnostics Pasteur. Has published 36 papers.
Christophe van der Linden, CEO, suAzio Consulting
Strategic partner to EuroGate. Master’s degree from the University of Limburg, an MBA from Vlerick University and 22 years’ experience in market research and marketing consulting. Background includes a deep focus on medical technologies. Comprehensive base of market research and consulting projects. Founded suAzio in December 2000.
Dr Don Cardy, Director, Medical Diagnostics
Twenty-five years medical diagnostics career with a Molecular Microbiology Doctrate and an experienced CEO, Board member and Project Manager of several related companies. A track record in capital raising, securing in-licencing agreements, maximisation of IP value creation and due diligence. Formerly held positions at Sonic Systems Research, Diagnostig, Oxford Innovations, Dragon Diagnostics, British Biocell International and Cytocell amongst others. Has more than 60 Patents, Applications, Registered Designs, Design Patents and 23 peer reviewed publications. A former Biomedical Sciences Honorary Lecturer at University of Bradford and University of Warwick Senior Research Fellow.
Dr Nick Pay, Director, Life Sciences Commercial Advisory
Globally experienced Tier-1 Life Sciences executive in Diagnostic/Genomics and Medtech. Formerly Roche Diagnostics and Oxford Gene Technology SVP – Strategic Planning. Former UK Sales and Marketing Director for Bayer (Corning Medical) and European Business Operations Director, Becton Dickinson. Ten years international commercialisation experience and author on the subject. Current member of Stevenage Bioscience Catalyst’s Strategic Advisory Board.
Dr Antonio Cheisi, Director, EuroGate Italy
Medical Doctor, Neurologist, active in Cancer, Neurodegenerative and Infectious disease translational research. Twenty years at Italian National Institute of Health (ISS) as Head of Research of Drug Research and Medicines Evaluation Dept, also international roles in multinational clinical research programs and represented Italy at the European Commission on behalf of the ISS. Currently CEO, HansaBioMed Life Sciences OU, a world-first developing Life Science products for EV/exosome research and CEO, Exosomics Siena SpA, a world leader in exosome-based cancer diagnostics and liquid biopsies. Biotech innovation scout and fundraiser.
Kensey Green, Director, Energy Sector & Special Projects
Formerly Director and Head of Public Sector of Nomura International plc for Northern & Central Europe having originally joined as Head of its Fixed Income syndicate. Twenty years senior Director roles at Commerzbank, Deutsche Bank, BNP, Bank of America, UBS and Investment Bank of Ireland. Extensive experience as entrepreneur in and consultant to the Renewable Energy sector, particularly biomass. Capital raised for several projects and has dealt with large sovereign, supranational bank and corporate borrowers in the global markets including Toyota, GE, Unilever, British Gas and Bayer.